Hodgkin lymphoma is a relatively rare disease among B-cell lymphomas; however, in recent years, new findings have been accumulated, such as the usefulness of PD-1 and PD-L1 immunohistochemistry for diagnosis, and effectiveness of immunotherapies using PD-L1 blockade. This evidence concerns the gene PDCD1 and B-cell non-Hodgkin lymphoma.